The Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1989

• Citation: S.I. 1989/969
• Sections: 3

Section 1 Citation, commencement and interpretation

(1) This Order, which may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1989, shall come into force on 9th June 1989.

(2) In this Order, “the principal Order ” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984 .

(3) In this Order, a reference to inserting an entry in a column in a Table of a Schedule to the principal Order shall be construed, in the case of an entry to be inserted in column 1, as a reference to inserting that entry at the appropriate point in the alphabetical order of the entries in column 1 of that Table and, in the case of an entry to be inserted, as the case may be, in column 2, 3 or 4 of that Table, as a reference to inserting that entry so as to appear against the column 1 entry against which it is listed in the Table set out in Schedule 1 or, as the case may be, Schedule 2 to this Order.

Section 2 Amendment of Schedule 1 to the principal Order

(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order) shall be amended in accordance with the following provisions of this article.

(2) In Table A (internal or external use)–

(a) there shall be inserted in column 1 and, as the case may be, columns 2, 3 and 4 those entries set out in columns 1, 2, 3 and 4 respectively of Schedule 1 to this Order; and

(b) for the entry “(1) 600mg” in column 2 relating to the substance “Benzalkonium Chloride”, there shall be substituted the entry “(1) 600mcg”.

(3) In Table B (external use only)–

(a) there shall be inserted in column 1 and, as the case may be, columns 2 and 3, those entries set out in columns 1, 2 and 3 respectively of Schedule 2 to this Order; and

(b) the entry “Turpentine Oil” in column 1 shall be deleted.

Section 3 Amendment of Schedule 2 to the principal Order

In Table A of Schedule 2 to the principal Order (which specifies the class of medicinal products the subject of a product licence of right on general sale by virtue of article 2(b) of the principal Order) the entry “Danthron” in column 1 and the corresponding entry “50mg(MD)” in column 4 shall be deleted.